Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release

ACS Nano

Volumn 6, Issue 5, 2012, Pages 4157-4168

  Peiris, Pubudu M ^a,b,c   Bauer, Lisa ^c   Toy, Randall ^a,c   Tran, Emily ^a,c   Pansky, Jenna ^a,c   Doolittle, Elizabeth ^a,c   Schmidt, Erik ^a,c   Hayden, Elliott ^a,c   Mayer, Aaron ^a,c   Keri, Ruth A ^b,c   Griswold, Mark A ^b,c   Karathanasis, Efstathios ^a,b,c  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Chemotherapy; Doxorubicin; Magnetic nanoparticles; Multicomponent nanoparticle; Nanochain; Radio frequency triggered drug release

Indexed keywords

DOXORUBICIN; DRUG RELEASE; MAGNETIC NANOPARTICLES; MULTICOMPONENTS; NANOCHAINS;

CARDIOVASCULAR SYSTEM; CELLS; CHEMOTHERAPY; MAMMALS; TUMORS;

NANOPARTICLES;

ANTINEOPLASTIC AGENT;

ANIMAL; ARTICLE; DISEASE MODEL; HUMAN; NANOTECHNOLOGY; NEOPLASM; RADIOFREQUENCY RADIATION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; HUMANS; NANOTECHNOLOGY; NEOPLASMS; RADIO WAVES; RATS;

EID: 84864670435     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn300652p     Document Type: Article

References (63)

1. Von Hoff, D. D.; Layard, M. W.; Basa, P.; Davis, H. L., Jr.; Von Hoff, A. L.; Rozencweig, M.; Muggia, F. M. Risk Factors for Doxorubicin-Induced Congestive Heart Failure. Ann. ntern. Med. 1979, 91, 710-717.
2. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review. J. Controlled Release 2000, 65, 271-284.
3. Lasic, D. D. Doxorubicin in Sterically Stabilized Liposomes. Nature 1996, 380, 561-562.
4. Dreher, M. R.; Liu, W.; Michelich, C. R.; Dewhirst, M. W.; Yuan, F.; Chilkoti, A. Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers. J. Natl. Cancer Inst. 2006, 98, 335-344.
5. Yuan, F. Transvascular Drug Delivery in Solid Tumors. Semin. Radiat. Oncol. 1998, 8, 164-175.
6. Pluen, A.; Boucher, Y.; Ramanujan, S.; McKee, T. D.; Gohongi, T.; Di Tomaso, E.; Brown, E. B.; Izumi, Y.; Campbell, R. B.; Berk, D. A.; et al. Role of Tumor-Host Interactions in Interstitial Diffusion of Macromolecules: Cranial vs. Subcutaneous Tumors. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 4628-4633.
7. Karathanasis, E.; Chan, L.; Karumbaiah, L.; McNeeley, K.; D'Orsi, C. J.; Annapragada, A. V.; Sechopoulos, I.; Bellamkonda, R. V. Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers. PLoS One 2009, 4, e5843.
8. Yuan, F.; Leunig, M.; Huang, S. K.; Berk, D. A.; Papahadjopoulos, D.; Jain, R. K. Microvascular Permeability and Interstitial Penetration of Sterically Stabilized (Stealth) Liposomes in a Human Tumor Xenograft. Cancer Res. 1994, 54, 3352-3356.
9. Karathanasis, E.; Chan, L.; Balusu, S. R.; D'Orsi, C. J.; Annapragada, A. V.; Sechopoulos, I.; Bellamkonda, R. V. Multifunctional Nanocarriers for Mammographic Quantification of Tumor Dosing and Prognosis of Breast Cancer Therapy. Biomaterials 2008, 29, 4815-4822.
10. Grantab, R.; Sivananthan, S.; Tannock, I. F. The Penetration of Anticancer Drugs through Tumor Tissue as a Function of Cellular Adhesion and Packing Density of Tumor Cells. Cancer Res. 2006, 66, 1033-1039.
11. Netti, P. A.; Berk, D. A.; Swartz, M. A.; Grodzinsky, A. J.; Jain, R. K. Role of Extracellular Matrix Assembly in Interstitial Transport in Solid Tumors. Cancer Res. 2000, 60, 2497-2503.
12. Kostarelos, K.; Emfietzoglou, D.; Papakostas, A.; Yang, W. H.; Ballangrud, A.; Sgouros, G. Binding and Interstitial Penetration of Liposomes within Avascular Tumor Spheroids. Int. J. Cancer 2004, 112, 713-721.
13. Terasaki, T.; Iga, T.; Sugiyama, Y.; Sawada, Y.; Hanano, M. Nuclear Binding as a Determinant of Tissue Distribution of Adriamycin, Daunomycin, Adriamycinol, Daunorubicinol and Actinomycin D. J. Pharmacobio-Dyn. 1984, 7, 269-277.
14. Marafino, B. J., Jr.; Giri, S. N.; Siegel, D. M. Pharmacokinetics, Covalent Binding and Subcellular Distribution of [3H]-Doxorubicin after Intravenous Administration in the Mouse. J. Pharmacol. Exp. Ther. 1981, 216, 55-61.
15. Laginha, K. M.; Verwoert, S.; Charrois, G. J.; Allen, T. M. Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors. Clin. Cancer Res. 2005, 11, 6944-6949.
16. Nagayasu, A.; Uchiyama, K.; Kiwada, H. The Size of Liposomes: A Factor Which Affects Their Targeting Efficiency to Tumors and Therapeutic Activity of Liposomal Antitumor Drugs. Adv. Drug Delivery Rev. 1999, 40, 75-87.
17. Lasic, D. D.; Frederik, P. M.; Stuart, M. C.; Barenholz, Y.; McIntosh, T. J. Gelation of Liposome Interior. A Novel Method for Drug Encapsulation. FEBS Lett. 1992, 312, 255-258.
18. Papahadjopoulos, D.; Allen, T. M.; Gabizon, A.; Mayhew, E.; Matthay, K.; Huang, S. K.; Lee, K. D.; Woodle, M. C.; Lasic, D. D.; Redemann, C.; et al. Sterically Stabilized Liposomes: Improvements in Pharmacokinetics and Antitumor Therapeutic Efficacy. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 11460-11464.
19. Peiris, P. M.; Schmidt, E.; Calabrese, M.; Karathanasis, E. Assembly of Linear Nano-Chains from Iron Oxide Nanospheres with Asymmetric Surface Chemistry. PLoS One 2011, 6, e15927.
20. Bolotin, E.; Cohen, R.; Bar, L.; Emanuel, N.; Ninio, S.; Lasic, D.; Barenholz, Y. Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes. J. Liposome Res. 1994, 4, 455-479.
21. Rauwerdink, A. M.; Weaver, J. B. Concurrent Quantification of Multiple Nanoparticle Bound States. Med. Phys. 2011, 38, 1136-1140.
22. Hunt, C. A. Liposomes Disposition in Vivo. V. Liposome Stability in Plasma and Implications for Drug Carrier Function. Biochim. Biophys. Acta 1982, 719, 450-463.
23. Agarwal, A.; Mackey, M. A.; El-Sayed, M. A.; Bellamkonda, R. V. Remote Triggered Release of Doxorubicin in Tumors by Synergistic Application of Thermosensitive Liposomes and Gold Nanorods. ACS Nano 2011, 5, 4919-4926.
24. Lasic, D.; Martin, F. Stealth Liposomes; CRC Press Inc.: Boca Raton, FL, 1995.
25. Govorov, A. O.; Richardson, H. H. Generating Heat with Metal Nanoparticles. Nano Today 2007, 2, 30-38.
26. Huang, H.; Delikanli, S.; Zeng, H.; Ferkey, D. M.; Pralle, A. Remote Control of Ion Channels and Neurons through Magnetic-Field Heating of Nanoparticles. Nat. Nanotechnol. 2010, 5, 602-606.
27. Gabizon, A.; Papahadjopoulos, D. Liposome Formulations with Prolonged Circulation Time in Blood and Enhanced Uptake by Tumors. Proc. Natl. Acad. Sci. U. S. A. 1988, 85, 6949-6953.
28. Gabizon, A.; Goren, D.; Horowitz, A. T.; Tzemach, D.; Lossos, A.; Siegal, T. Long-Circulating Liposomes for Drug Delivery in Cancer Therapy: A Review of Biodistribution Studies in Tumor-Bearing Animals. Adv. Drug Delivery Rev. 1997, 24, 337-344.
29. Rose, P. G. PEGylated Liposomal Doxorubicin: Optimizing the Dosing Schedule in Ovarian Cancer. Oncologist 2005, 10, 205-214.
30. McNeeley, K. M.; Karathanasis, E.; Annapragada, A. V.; Bellamkonda, R. V. Masking and Triggered Unmasking of Targeting Ligands on Nanocarriers to Improve Drug Delivery to Brain Tumors. Biomaterials 2009, 30, 3986-3995.
31. Agarwal, A.; Jaye, D. L.; Giegerman, C. M.; Bellamkonda, R. V. Rational Identification of a Novel Peptide for Targeting Nanocarriers to 9L Glioma. J Biomed Mater Res A 2008, 87, 728-738.
32. Karathanasis, E.; Suryanarayanan, S.; Balusu, S. R.; McNeeley, K.; Sechopoulos, I.; Karellas, A.; Annapragada, A. V.; Bellamkonda, R. V. Imaging Nanoprobe for Prediction of Outcome of Nanoparticle Chemotherapy by Using Mammography. Radiology 2009, 250, 398-406.
33. Campos, S. Liposomal Anthracyclines: Adjuvant and Neoadjuvant Therapy for Breast Cancer. Oncologist 2003, 8, 10-16.
34. O'Shaughnessy, J. Liposomal Anthracyclines for Breast Cancer: Overview. Oncologist 2003, 8, 1-2.
35. Rivera, E. Liposomal Anthracyclines in Metastatic Breast Cancer: Clinical Update. Oncologist 2003, 8, 3-9.
36. Clinicaltrials.gov, sponsored by NIH; Accessed 11/11/2011 URL: http://clinicaltrials.gov/.
37. Parish, C. R.; Freeman, C.; Brown, K. J.; Francis, D. J.; Cowden, W. B. Identification of Sulfated Oligosaccharide-Based Inhibitors of Tumor Growth and Metastasis Using Novel In Vitro Assays for Angiogenesis and Heparanase Activity. Cancer Res. 1999, 59, 3433-3441.
38. Xing, R. H.; Mazar, A.; Henkin, J.; Rabbani, S. A. Prevention of Breast Cancer Growth, Invasion, and Metastasis by Antiestrogen Tamoxifen Alone or in Combination with Urokinase Inhibitor B-428. Cancer Res. 1997, 57, 3585-3593.
39. Simoes, S.; Moreira, J. N.; Fonseca, C.; Duzgunes, N.; de Lima, M. C. On the Formulation of pH-Sensitive Liposomes with Long Circulation Times. Adv. Drug Delivery Rev. 2004, 56, 947-965.
40. Brazel, C. S. Magnetothermally-Responsive Nanomaterials: Combining Magnetic Nanostructures and Thermally-Sensitive Polymers for Triggered Drug Release. Pharm. Res. 2009, 26, 644-656.
41. Tai, L. A.; Tsai, P. J.; Wang, Y. C.; Wang, Y. J.; Lo, L. W.; Yang, C. S. Thermosensitive Liposomes Entrapping Iron Oxide Nanoparticles for Controllable Drug Release. Nanotechnology 2009, 20, 135101.
42. Lee, J. H.; Jang, J. T.; Choi, J. S.; Moon, S. H.; Noh, S. H.; Kim, J. W.; Kim, J. G.; Kim, I. S.; Park, K. I.; Cheon, J. Exchange-Coupled Magnetic Nanoparticles for Efficient Heat Induction. Nat. Nanotechnol. 2011, 6, 418-422.
43. Yavuz, M. S.; Cheng, Y.; Chen, J.; Cobley, C. M.; Zhang, Q.; Rycenga, M.; Xie, J.; Kim, C.; Song, K. H.; Schwartz, A. G.; et al. Gold Nanocages Covered by Smart Polymers for Controlled Release with Near-Infrared Light. Nat. Mater. 2009, 8, 935-939.
44. Li, W.; Cai, X.; Kim, C.; Sun, G.; Zhang, Y.; Deng, R.; Yang, M.; Chen, J.; Achilefu, S.; Wang, L. V.; et al. Gold Nanocages Covered with Thermally-Responsive Polymers for Controlled Release by High-Intensity Focused Ultrasound. Nanoscale 2011, 3, 1724-1730.
45. Moon, G. D.; Choi, S. W.; Cai, X.; Li, W.; Cho, E. C.; Jeong, U.; Wang, L. V.; Xia, Y. A New Theranostic System Based on Gold Nanocages and Phase-Change Materials with Unique Features for Photoacoustic Imaging and Controlled Release. J. Am. Chem. Soc. 2011, 133, 4762-4765.
46. Rapoport, N.; Gao, Z.; Kennedy, A. Multifunctional Nanoparticles for Combining Ultrasonic Tumor Imaging and Targeted Chemotherapy. J. Natl. Cancer Inst. 2007, 99, 1095-1106.
47. Lum, A. F.; Borden, M. A.; Dayton, P. A.; Kruse, D. E.; Simon, S. I.; Ferrara, K. W. Ultrasound Radiation Force Enables Targeted Deposition of Model Drug Carriers Loaded on Microbubbles. J. Controlled Release 2006, 111, 128-134.
48. Kheirolomoom, A.; Dayton, P. A.; Lum, A. F.; Little, E.; Paoli, E. E.; Zheng, H.; Ferrara, K. W. Acoustically-Active Microbubbles Conjugated to Liposomes: Characterization of a Proposed Drug Delivery Vehicle. J. Controlled Release 2007, 118, 275-284.
49. Huang, X.; El-Sayed, I. H.; Qian, W.; El-Sayed, M. A. Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods. J. Am. Chem. Soc. 2006, 128, 2215-2120.
50. Sardar, R.; Shumaker-Parry, J. S. Asymmetrically Functionalized Gold Nanoparticles Organized in One-Dimensional Chains. Nano Lett. 2008, 8, 731-736.
51. Park, J. H.; von Maltzahn, G.; Zhang, L.; Derfus, A. M.; Simberg, D.; Harris, T. J.; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Systematic Surface Engineering of Magnetic Nanoworms for In Vivo Tumor Targeting. Small 2009, 5, 694-700.
52. Park, J. H.; von Maltzahn, G.; Zhang, L. L.; Schwartz, M. P.; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv. Mater. 2008, 20, 1630-1635.
53. Dai, Q.; Worden, J. G.; Trullinger, J.; Huo, Q. A " Nanonecklace" Synthesized from Monofunctionalized Gold Nanoparticles. J. Am. Chem. Soc. 2005, 127, 8008-8009.
54. Chithrani, B. D.; Ghazani, A. A.; Chan, W. C. Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells. Nano Lett. 2006, 6, 662-668.
55. Sharma, G.; Valenta, D. T.; Altman, Y.; Harvey, S.; Xie, H.; Mitragotri, S.; Smith, J. W. Polymer Particle Shape Independently Influences Binding and Internalization by Macrophages. J. Controlled Release 2010, 147, 408-412.
56. Geng, Y.; Dalhaimer, P.; Cai, S.; Tsai, R.; Tewari, M.; Minko, T.; Discher, D. E. Shape Effects of Filaments versus Spherical Particles in Flow and Drug Delivery. Nat. Nanotechnol. 2007, 2, 249-255.
57. Champion, J. A.; Mitragotri, S. Role of Target Geometry in Phagocytosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 4930-4934.
58. Muller, I.; Niethammer, D.; Bruchelt, G. Anthracycline-Derived Chemotherapeutics in Apoptosis and Free Radical Cytotoxicity (Review). Int. J. Mol. Med. 1998, 1, 491-494.
59. Tewey, K. M.; Rowe, T. C.; Yang, L.; Halligan, B. D.; Liu, L. F. Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II. Science 1984, 226, 466-468.
60. Levin, M.; Silber, R.; Israel, M.; Goldfeder, A.; Khetarpal, V. K.; Potmesil, M. Protein-Associated DNA Breaks and DNAProtein Cross-Links Caused by DNA Nonbinding Derivatives of Adriamycin in L1210 Cells. Cancer Res. 1981, 41, 1006-1010.
61. Kellner, U.; Sehested, M.; Jensen, P. B.; Gieseler, F.; Rudolph, P. Culprit and Victim;DNA Topoisomerase II. Lancet Oncol. 2002, 3, 235-243.
62. Eom, Y. W.; Kim, M. A.; Park, S. S.; Goo, M. J.; Kwon, H. J.; Sohn, S.; Kim, W. H.; Yoon, G.; Choi, K. S. Two Distinct Modes of Cell Death Induced by Doxorubicin: Apoptosis and Cell Death through Mitotic Catastrophe Accompanied by Senescencelike Phenotype. Oncogene 2005, 24, 4765-4777.
63. Yori, J. L.; Seachrist, D. D.; Johnson, E.; Lozada, K. L.; Abdul-Karim, F. W.; Chodosh, L. A.; Schiemann, W. P.; Keri, R. A. Kruppel-like Factor 4 Inhibits Tumorigenic Progression and Metastasis in a Mouse Model of Breast Cancer. Neoplasia 2011, 13, 601-610.